Search

Copyright of Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Masked hypertension (MH) is defined as a clinical condition in which patients have normal office blood pressure (BP) values (systolic BP <140 mm Hg, and diastolic BP <90 mmHg), but high ambulatory blood pressure measurements values (systolic BP >140 mmHg, and diastolic BP >90 mmHg). The prevalance of masked hypertension is reported as 10-40% in recent observational studies. Although the basic mechanism of that disease has not been well-defined yet. However it has been thought that it may be associated with smoking, alcohol abuse and obesity. The increment in the incidence of end-organ damage and cardiovascular disease risk in patient with masked hypertension is similar to essential hypertension. Therefore the guidelines suggest medical treatment for patient with masked hypertension to prevent worse cardiovascular outcomes. [ABSTRACT FROM AUTHOR]